Clinical efficacy and safety of anti-PD-1/PD-L1 treatments in non-small cell lung cancer (NSCLC)
Aims The present study was performed to investigate the efficacy and safety of anti-programmed death-1 (PD-1)/programmed death-ligand-1 (PD-L1) treatments in non-small cell lung cancer (NSCLC).Methods The potential articles were searched from Pubmed and Embase. The end points included overall surviv...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Taylor & Francis Group
2019-12-01
|
| Серія: | Artificial Cells, Nanomedicine, and Biotechnology |
| Предмети: | |
| Онлайн доступ: | https://www.tandfonline.com/doi/10.1080/21691401.2019.1687499 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|